FG
IRMD icon

Formula Growth’s iRadimed IRMD Stock Holding History

Formula Growth’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-15,000
Closed -$420K – 167
2015
Q4 		$420K Buy
+15,000
New +$424K 0.1% 150

Other funds holding IRMD

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM

Formula Growth's IRMD Position: Q1 2016 in Review

Formula Growth sold out of iRadimed (IRMD) in Q1 2016, closing a stake of 15,000 shares — an estimated $420K sold.

Formula Growth first reported a position in IRMD in Q4 2015 and held it in 1 quarter. The position peaked at $420K in Q4 2015. 66 funds tracked by Wall St. Rank hold IRMD as of Q1 2016.

  • Formula Growth reported no remaining iRadimed position as of Q1 2016 after selling out during the quarter.
  • Formula Growth sold 15,000 iRadimed shares in Q1 2016, an estimated $420K.
  • Formula Growth first reported a position in iRadimed in Q4 2015 and held it in 1 quarter.
  • Formula Growth's iRadimed position peaked at $420K in Q4 2015.
  • 66 funds tracked by Wall St. Rank held iRadimed as of Q1 2016.

Based on Formula Growth's 13F filing for Q1 2016, filed 15 Aug 2016.